Boehringer Ingelheim and Gubra announce new collaboration to develop anti-obesity peptide poly-agonists
INGELHEIM, Germany & HRSHOLM, Denmark--(BUSINESS WIRE)--May 29, 2019--
INGELHEIM, Germany & HRSHOLM, Denmark--(BUSINESS WIRE)--May 29, 2019--